Therapeutic Time Window and Dose Dependence of Xenon Delivered via Echogenic Liposomes for Neuroprotection in Stroke.

CONCLUSION: This study demonstrates the therapeutic efficacy of Xe-ELIP administered within 5 h after stroke onset with an optimal dosage range of 7-14 mg/kg for maximal neuroprotection. PMID: 23981565 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23981565?dopt=Abstract

Source: CNS Neuroscience and Therapeutics - August 24, 2013 Category: Neuroscience Authors: Peng T, Britton GL, Kim H, Cattano D, Aronowski J, Grotta J, McPherson DD, Huang SL Tags: CNS Neurosci Ther Source Type: research